Related Experiment Video

Updated: Jul 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Ubiquitin-dependent regulation of TGFbeta signaling in cancer

Luisa Izzi1, Liliana Attisano

  • 1Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.

Neoplasia (New York, N.Y.)
|August 24, 2006
PubMed

Insights

The transforming growth factor-beta (TGFbeta) pathway regulates cell functions and is vital for preventing cancer. Disruptions in TGFbeta signaling and its regulation by the ubiquitin-proteasome system contribute to cancer development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The transforming growth factor-beta (TGFbeta) superfamily controls critical cellular processes like proliferation, differentiation, and apoptosis.
  • TGFbeta signaling involves serine/threonine kinase receptors and Smad proteins, with pathway dysregulation linked to human cancers.
  • Maintaining TGFbeta signaling homeostasis is crucial for preventing carcinogenesis.

Purpose of the Study:

  • To explore the intricate relationship between the ubiquitin-proteasome system and TGFbeta signaling in the context of cancer.
  • To elucidate how the ubiquitin-dependent degradation of TGFbeta pathway components influences cancer development and progression.

Main Methods:

  • Review of existing literature on TGFbeta signaling pathways.
  • Analysis of the role of the ubiquitin-proteasome system in regulating TGFbeta effectors.
  • Examination of genetic alterations in TGFbeta pathway components associated with cancer.

Main Results:

  • Genetic alterations in the TGFbeta pathway are implicated in various human cancers.
  • The ubiquitin-proteasome system is a key regulator of TGFbeta signaling effectors.
  • Disruption of ubiquitin-dependent degradation within the TGFbeta pathway promotes cancer development and progression.

Conclusions:

  • The interplay between TGFbeta signaling and the ubiquitin-proteasome system is critical for cellular homeostasis and cancer prevention.
  • Understanding this molecular crosstalk advances knowledge of cancer etiology and progression.
  • Targeting these pathways may offer novel therapeutic strategies for cancer treatment.

More Related Videos

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...